Nu Skin Enterprises, Inc.

NUS Consumer Defensive Household & Personal Products

Nu Skin Enterprises, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 14.3% from fiscal 2024. In the quarter to June 2026, revenue fell 17.1%, EPS fell 1,295.4%, free cash flow fell 86.1% and total debt fell 14.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

4.87 0.13 +2.74%
Market cap
$237.1M
P/E
0.0×
Fwd P/E
5.9×
Dividend yield
4.93%
F-score
7/9
Altman Z
3.78
Beneish M
−2.35
Dividend safety
70/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(32.53%) 7.04% 22.00% 14.55%

+8 more TTM periods

Piotroski F-Score
4 7 7 6
ROA
(16.87%) 3.94% 11.15% 7.29%
ROIC
(1.15%) 6.09% 5.21% (0.85%)
Return on Tangible Assets
(34.27%) 8.42% 24.23% 16.38%
Average Days of Receivables
12.98 11.40 9.72 11.44
Free Cash Flow per Share
0.22 0.86 0.93 1.08
Free Cash Flow
10.78 41.57 46.01 53.35
Capital Expenditures
(40.03) (34.41) (34.28) (36.10)
Other line items
Cash ROIC
1.14% 3.41% 3.62% 4.16%
Accounts Receivable Turnover
25.33 28.37 32.88 26.51
Accounts Payable Turnover
12.76 14.18 14.86 16.71
Inventory Turnover
2.28 2.41 2.46 2.40
Average Days of Payables
32.48 23.77 21.06 20.34
Days of Inventory on Hand
164.94 147.36 143.70 127.32
Tax Rate
7.20 (0.15) (0.18) (0.09)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
64.07% 63.65% 63.33% 63.33%
Share Based Compensation of Revenue
1.00% 1.28% 1.62% 1.56%
Interest Coverage
(0.66) 5.34 4.71 (0.67)
Operating CF/Net income
(0.23) 1.39 0.50 0.82
Depreciation/Fixed assets
0.13 0.13 0.14 0.15
Capex/Depreciation
(0.80) (0.68) (0.66) (0.65)
Revenue per Share
28.30 29.90 30.13 31.59
Operating CF per Share
1.05 1.58 1.63 1.81
Capex per Share
(0.82) (0.71) (0.70) (0.73)
Capex to Sales
0.03 0.02 0.02 0.02

Fold the line items

Columns are period end dates